课题基金 / 基金详情

PROTEIN INTERACTIONS IN HERPESVIRUS CELL FUSION

PROTEIN INTERACTIONS IN HERPESVIRUS CELL FUSION
疱疹病毒细胞融合中的蛋白质相互作用
批准号:
2671615
负责人:
Robert James Geraghty
金额:
$3.05万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-07-01 至

项目摘要

项目成果

Robert James Geraghty的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term objective of this research proposal is to identify the viral and cellular components involved in cell fusion mediated by herpes simplex virus (HSV). An intimate understanding of cell fusion induced by HSV may facilitate effective treatments to prevent such cell-to-cell spread in infected individuals. An understanding of cell-to-cell fusion mediated by HSV may also provide insight into virus-to-cell fusion because the two processes require overlapping sets of proteins. This proposal outlines three different approaches to identify cellular or viral proteins that interact with the mutant or wild-type forms of two envelope glycoproteins of HSV-1 required for cell fusion, gB and gH. The first approach will be to utilize the two-hybrid system in yeast to identify gB- or gH-interacting proteins. The two-hybrid system is a genetic screen performed in yeast expressing a cDNA library to discover viral or cellular proteins that interact with mutant or wild-type cytoplasmic domains of gB or gH. The second approach will be to attempt to co-immunoprecipitate cellular or viral proteins that are interacting with mutant or wild-type forms of gB or gH in infected cells. The third approach will be to fuse mutant or wild- type versions of the cytoplasm tail of gB or gH to glutathione-S- transferase and determine if cellular or viral proteins will bind to such fusion proteins that are immobilized on columns.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein
  • 批准号:
    10318943
  • 项目类别:
  • 资助金额:
    $65.45万
  • 财政年份:
    2019
  • 负责人:
    Robert James Geraghty
  • 依托单位:
Discovery and development of novel anti-HCMV agents targeting the UL89 terminase protein
  • 批准号:
    10534193
  • 项目类别:
  • 资助金额:
    $65.45万
  • 财政年份:
    2019
  • 负责人:
    Robert James Geraghty
  • 依托单位:
Membrane fusion during HSV-1 entry
  • 批准号:
    7447258
  • 项目类别:
  • 资助金额:
    $7.55万
  • 财政年份:
    2009
  • 负责人:
    Robert James Geraghty
  • 依托单位:
Membrane fusion during HSV-1 entry
  • 批准号:
    7843510
  • 项目类别:
  • 资助金额:
    $7.55万
  • 财政年份:
    2009
  • 负责人:
    Robert James Geraghty
  • 依托单位:
海外基金